表紙
市場調査レポート

吸入器:医療機器のパイプライン評価

Inhalers - Medical Devices Pipeline Assessment, 2015

発行 GlobalData 商品コード 348464
出版日 ページ情報 英文 125 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
吸入器:医療機器のパイプライン評価 Inhalers - Medical Devices Pipeline Assessment, 2015
出版日: 2015年12月09日 ページ情報: 英文 125 Pages
概要

当レポートでは、吸入器のパイプライン製品について調査分析し、開発段階別の比較分析に焦点を当てて、パイプライン製品の開発に従事している主要企業、進行中の臨床試験に関する情報なども含めて、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

  • 吸入器の概要

第3章 開発中の製品

  • 吸入器 - パイプライン製品:開発段階別
  • 吸入器 - パイプライン製品:セグメント別
  • 吸入器 - パイプライン製品:地域別
  • 吸入器 - パイプライン製品:規制別
  • 吸入器 - パイプライン製品:承認予定日別
  • 吸入器 - 進行中の臨床試験

第4章 吸入器 - 開発中のパイプライン製品:企業別

  • 吸入器企業 - パイプライン製品:開発段階別
  • 吸入器 - パイプライン製品:開発段階別

第5章 吸入器企業と製品の概要

  • Adamis Pharmaceuticals Corporation
  • Advent Pharmaceuticals Pty Ltd
  • Aespira Ltd.
  • Akela Pharma Inc. (休止中)
  • Alexza Pharmaceuticals, Inc.
  • Bayer HealthCare AG
  • Bellerophon Therapeutics LLC
  • Bespak Europe Ltd.
  • Cipla Ltd.
  • CN Creative
  • Drexel University
  • FocusStart Orthosensors
  • GlaxoSmithKline Plc
  • Hovione FarmaCiencia SA
  • MannKind Corporation
  • Medihale Ltd.
  • Nanotherapeutics, Inc.
  • Nektar Therapeutics
  • North Carolina State University
  • Novartis AG
  • OPKO Health, Inc.
  • Pharmaxis Limited
  • Respira Therapeutics, Inc.
  • Sandoz International GmbH
  • Sheffield Hallam University
  • 新日本科学
  • SHL Medical
  • SkyePharma Plc
  • Teva Pharmaceutical Industries Limited
  • University of Kansas

第6章 吸入器 - 最近の動向

第7章 付録

図表

目次
Product Code: GDME0125EPD

GlobalData's Medical Devices sector report, "Inhalers - Medical Devices Pipeline Assessment, 2015" provides an overview of Inhalers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Inhalers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Inhalers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Inhalers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Inhalers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Inhalers Overview

3. Products under Development

  • 3.1. Inhalers - Pipeline Products by Stage of Development
  • 3.2. Inhalers - Pipeline Products by Segment
  • 3.3. Inhalers - Pipeline Products by Territory
  • 3.4. Inhalers - Pipeline Products by Regulatory Path
  • 3.5. Inhalers - Pipeline Products by Estimated Approval Date
  • 3.6. Inhalers - Ongoing Clinical Trials

4. Inhalers - Pipeline Products under Development by Companies

  • 4.1. Inhalers Companies - Pipeline Products by Stage of Development
  • 4.2. Inhalers - Pipeline Products by Stage of Development

5. Inhalers Companies and Product Overview

  • 5.1. Adamis Pharmaceuticals Corporation Company Overview
    • 5.1.1. Adamis Pharmaceuticals Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Advent Pharmaceuticals Pty Ltd Company Overview
    • 5.2.1. Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Aespira Ltd. Company Overview
    • 5.3.1. Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Akela Pharma Inc. (Inactive) Company Overview
    • 5.4.1. Akela Pharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Alexza Pharmaceuticals, Inc. Company Overview
    • 5.5.1. Alexza Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Bayer HealthCare AG Company Overview
    • 5.6.1. Bayer HealthCare AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Bellerophon Therapeutics LLC Company Overview
    • 5.7.1. Bellerophon Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Bespak Europe Ltd. Company Overview
    • 5.8.1. Bespak Europe Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Cipla Ltd. Company Overview
    • 5.9.1. Cipla Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. CN Creative Company Overview
    • 5.10.1. CN Creative Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Drexel University Company Overview
    • 5.11.1. Drexel University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. FocusStart Orthosensors Company Overview
    • 5.12.1. FocusStart Orthosensors Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. GlaxoSmithKline Plc Company Overview
    • 5.13.1. GlaxoSmithKline Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Hovione FarmaCiencia SA Company Overview
    • 5.14.1. Hovione FarmaCiencia SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. MannKind Corporation Company Overview
    • 5.15.1. MannKind Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Medihale Ltd. Company Overview
    • 5.16.1. Medihale Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Nanotherapeutics, Inc. Company Overview
    • 5.17.1. Nanotherapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Nektar Therapeutics Company Overview
    • 5.18.1. Nektar Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. North Carolina State University Company Overview
    • 5.19.1. North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Novartis AG Company Overview
    • 5.20.1. Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. OPKO Health, Inc. Company Overview
    • 5.21.1. OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Pharmaxis Limited Company Overview
    • 5.22.1. Pharmaxis Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Respira Therapeutics, Inc. Company Overview
    • 5.23.1. Respira Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. Sandoz International GmbH Company Overview
    • 5.24.1. Sandoz International GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Sheffield Hallam University Company Overview
    • 5.25.1. Sheffield Hallam University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. Shin Nippon Biomedical Laboratories, Ltd. Company Overview
    • 5.26.1. Shin Nippon Biomedical Laboratories, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. SHL Medical Company Overview
    • 5.27.1. SHL Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. SkyePharma Plc Company Overview
    • 5.28.1. SkyePharma Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. Teva Pharmaceutical Industries Limited Company Overview
    • 5.29.1. Teva Pharmaceutical Industries Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. University of Kansas Company Overview
    • 5.30.1. University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. University of Texas Medical Branch at Galveston Company Overview
    • 5.31.1. University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview

6. Inhalers- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Inhalers - Pipeline Products by Stage of Development
  • Table 2: Inhalers - Pipeline Products by Segment
  • Table 3: Inhalers - Pipeline Products by Territory
  • Table 4: Inhalers - Pipeline Products by Regulatory Path
  • Table 5: Inhalers - Pipeline Products by Estimated Approval Date
  • Table 6: Inhalers - Ongoing Clinical Trials
  • Table 7: Inhalers Companies - Pipeline Products by Stage of Development
  • Table 8: Inhalers - Pipeline Products by Stage of Development
  • Table 9: Adamis Pharmaceuticals Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: 3M Taper Dry Powder Inhaler - Product Status
  • Table 11: 3M Taper Dry Powder Inhaler - Product Description
  • Table 12: APC-5000 - Dry Powder Inhaler - Product Status
  • Table 13: APC-5000 - Dry Powder Inhaler - Product Description
  • Table 14: Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: g60 Dry Powder Inhaler - Product Status
  • Table 16: g60 Dry Powder Inhaler - Product Description
  • Table 17: Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: resQhaler - Product Status
  • Table 19: resQhaler - Product Description
  • Table 20: Akela Pharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Fentanyl TAIFUN Inhaler - Product Status
  • Table 22: Fentanyl TAIFUN Inhaler - Product Description
  • Table 23: Alexza Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Staccato System - Disposable Single Dose - Product Status
  • Table 25: Staccato System - Disposable Single Dose - Product Description
  • Table 26: Staccato System - Multiple Dose - Product Status
  • Table 27: Staccato System - Multiple Dose - Product Description
  • Table 28: Bayer HealthCare AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Ciprofloxacin Dry Powder Inhaler - Product Status
  • Table 30: Ciprofloxacin Dry Powder Inhaler - Product Description
  • Table 31: Bellerophon Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: Mark2 Device - Product Status
  • Table 33: Mark2 Device - Product Description
  • Table 34: Bespak Europe Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: DEV610 - Product Status
  • Table 36: DEV610 - Product Description
  • Table 37: Cipla Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: Synchrobreathe - Product Status
  • Table 39: Synchrobreathe - Product Description
  • Table 40: CN Creative Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: Nicadex Electronic Inhaler - Product Status
  • Table 42: Nicadex Electronic Inhaler - Product Description
  • Table 43: Drexel University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: BREATHE Inhaler - Product Status
  • Table 45: BREATHE Inhaler - Product Description
  • Table 46: FocusStart Orthosensors Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: Smart Inhaler - Product Status
  • Table 48: Smart Inhaler - Product Description
  • Table 49: GlaxoSmithKline Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: Gemini Multi-Dose Combination Inhaler - Product Status
  • Table 51: Gemini Multi-Dose Combination Inhaler - Product Description
  • Table 52: Hovione FarmaCiencia SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 53: XCaps - Product Status
  • Table 54: XCaps - Product Description
  • Table 55: MannKind Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: Dreamboat - Product Status
  • Table 57: Dreamboat - Product Description
  • Table 58: Medihale Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Toucan Multi-Dose Inhaler - Product Status
  • Table 60: Toucan Multi-Dose Inhaler - Product Description
  • Table 61: Nanotherapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: GelVac Intranasal Powder Vaccine Delivery System - Product Status
  • Table 63: GelVac Intranasal Powder Vaccine Delivery System - Product Description
  • Table 64: NanoGENT - Product Status
  • Table 65: NanoGENT - Product Description
  • Table 66: Nektar Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 67: Nektar Dry Powder Inhaler - Amikacin - Product Status
  • Table 68: Nektar Dry Powder Inhaler - Amikacin - Product Description
  • Table 69: North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 70: Smart Inhaler System - Product Status
  • Table 71: Smart Inhaler System - Product Description
  • Table 72: Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 73: Ultibro Breezhaler - Product Status
  • Table 74: Ultibro Breezhaler - Product Description
  • Table 75: Novartis AG - Ongoing Clinical Trials Overview
  • Table 76: Ultibro Breezhaler - The Effectiveness of Single Dose Ultibro Breezhaler (Indacaterol/Glycopyrronium) by Sd-DPI Versus Ipratropium/Salbutamol by Nebulizer in Improving FEV1 and Dyspnea During Stable State of COPD
  • Table 77: OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 78: Inspiromatic - Product Status
  • Table 79: Inspiromatic - Product Description
  • Table 80: Pharmaxis Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 81: Orbital Dry Powder Inhaler - Product Status
  • Table 82: Orbital Dry Powder Inhaler - Product Description
  • Table 83: Respira Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 84: Dry Powder Inhaler - Product Status
  • Table 85: Dry Powder Inhaler - Product Description
  • Table 86: Sandoz International GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 87: Solis Multi-Dose Dry Powder Inhaler - Product Status
  • Table 88: Solis Multi-Dose Dry Powder Inhaler - Product Description
  • Table 89: Unit-Dose Dry Powder Inhaler - Product Status
  • Table 90: Unit-Dose Dry Powder Inhaler - Product Description
  • Table 91: Sheffield Hallam University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 92: Dry Powder Inhaler - Product Status
  • Table 93: Dry Powder Inhaler - Product Description
  • Table 94: Shin Nippon Biomedical Laboratories, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 95: µco System - Product Status
  • Table 96: µco System - Product Description
  • Table 97: SHL Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Table 98: Breath Operated Inhaler - Product Status
  • Table 99: Breath Operated Inhaler - Product Description
  • Table 100: TobrAir - Product Status
  • Table 101: TobrAir - Product Description
  • Table 102: SkyePharma Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 103: Flutiform Breath-Actuated Inhaler - Product Status
  • Table 104: Flutiform Breath-Actuated Inhaler - Product Description
  • Table 105: Teva Pharmaceutical Industries Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 106: QVAR Breath-actuated Inhaler (BAI) - Product Status
  • Table 107: QVAR Breath-actuated Inhaler (BAI) - Product Description
  • Table 108: Spiromax EU / mDPI US - Product Status
  • Table 109: Spiromax EU / mDPI US - Product Description
  • Table 110: Tidal Inhaler - Product Status
  • Table 111: Tidal Inhaler - Product Description
  • Table 112: University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
  • Table 113: Dry Powder Inhaler - Product Status
  • Table 114: Dry Powder Inhaler - Product Description
  • Table 115: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
  • Table 116: Dry Powder Drug Delivery System - Product Status
  • Table 117: Dry Powder Drug Delivery System - Product Description
  • Table 118: Glossary

List of Figures

  • Figure 1: Inhalers - Pipeline Products by Stage of Development
  • Figure 2: Inhalers - Pipeline Products by Segment
  • Figure 3: Inhalers - Pipeline Products by Territory
  • Figure 4: Inhalers - Pipeline Products by Regulatory Path
  • Figure 5: Inhalers - Pipeline Products by Estimated Approval Date
  • Figure 6: Inhalers - Ongoing Clinical Trials
Back to Top